Cargando…
Bioactive constituents isolated from Atractylodes lancea (Thunb.) DC. rhizome exhibit synergistic effect against cholangiocarcinoma cell
BACKGROUND: Cholangiocarcinoma (CCA) is the primary type of bile duct cancer with high morbidity and mortality, particularly in patients with advanced-stage disease. Treatment of CCA remains unsatisfactory due to the lack of sensitive and specific diagnostic tool for early detection as well as effec...
Autores principales: | Martviset, Pongsakorn, Chaijaroenkul, Wanna, Muhamad, Phunuch, Na-Bangchang, Kesara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207387/ https://www.ncbi.nlm.nih.gov/pubmed/30498376 http://dx.doi.org/10.2147/JEP.S177032 |
Ejemplares similares
-
Suppression of Cholangiocarcinoma Cell Growth and Proliferation by Atractylodes lancea (Thunb) DC. through ERK-Signaling Cascade
por: Martviset, Pongsakorn, et al.
Publicado: (2021) -
Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway
por: Vanaroj, Peeranate, et al.
Publicado: (2023) -
Research and Development of Atractylodes lancea (Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics
por: Na-Bangchang, Kesara, et al.
Publicado: (2017) -
Apoptotic and Anti-metastatic Effects of Atractylodes lancea (Thunb.) DC. in a Hamster Model of Cholangiocarcinoma
por: Sonsomnuek, Paradon, et al.
Publicado: (2022) -
Preclinical studies of toxicity and anti-cholangiocarcinoma activity of the standardized capsule formulation of Atractylodes lancea (Thunb.) DC
por: Plengsuriyakarn, Tullayakorn, et al.
Publicado: (2023)